Related Experiment Videos
Cost analysis of a home intravenous antibiotic program
T M Chamberlain1, M E Lehman, M J Groh
1Department of Pharmacy Services, Medical College of Virginia (MCV) Hospitals, Richmond.
American Journal of Hospital Pharmacy
|November 1, 1988
Summary
This study found that home intravenous antibiotic programs are feasible and cost-effective. Patients received home antibiotic therapy for an average of 26 days, reducing overall treatment costs significantly.
Area of Science:
- Pharmacoeconomics
- Health Services Research
- Infectious Disease Management
Background:
- Home intravenous antibiotic therapy offers an alternative to prolonged inpatient care.
- Evaluating the economic impact of such programs is crucial for healthcare resource allocation.
Purpose of the Study:
- To conduct a cost analysis of a home intravenous antibiotic program.
- To assess the feasibility and cost-effectiveness of home-based antibiotic treatment.
Main Methods:
- Fiscal data from 10 patients undergoing home intravenous antibiotic therapy were collected.
- Costs included antibiotics, supplies, laboratory tests, hospital room, and personnel.
- Charges were converted to costs using cost-to-charge ratios.
- A subgroup of six osteomyelitis patients underwent detailed fiscal analysis.
Main Results:
- The mean duration of home therapy was 26 days, compared to 15.9 days of inpatient treatment.
- No major catheter-related complications were reported.
- For osteomyelitis patients, total therapy cost was $57,854 at home versus a projected $98,314 for inpatient care.
Conclusions:
- The home intravenous antibiotic program demonstrated feasibility.
- The program was found to be a cost-effective alternative to inpatient antibiotic administration.